Compare Dyne Therapeutics Inc. Common Stock (DYN) vs Hyatt Hotels Corporation (H) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dyne Therapeutics Inc. Common Stock vs Hyatt Hotels Corporation — how do they compare? Dyne Therapeutics Inc. Common Stock trades at $15.09 (market cap $2.86B), while Hyatt Hotels Corporation trades at $160.32 (market cap $15.35B). The key difference: Hyatt Hotels Corporation is far larger — about 5.4× Dyne Therapeutics Inc. Common Stock's market cap, and Hyatt Hotels Corporation pays a 0.37% dividend while Dyne Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dyne Therapeutics Inc. Common Stock for 0 Days and Hyatt Hotels Corporation for 149 Days on average.
| DYN | H | |
|---|---|---|
Market Cap | $2.86B | $15.35B |
Volume | 3,341,579 | 614,954 |
Sector | Health | Consumer Cyclical |
52-Week High | $26.78 | $202.09 |
52-Week Low | $14.60 | $135.42 |
Typical Hold Time | 0 Days | 149 Days |
Enterprise Value | $2.18B | $19.26B |
Dividend Yield | — | 0.37% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dyne Therapeutics (DYN) trades at $15.30, down 4.14% on the day, reflecting recent volatility amid mixed clinical trial news. The stock is in a neutral technical position with immediate support at $15 and resistance at $16. Fundamentally, the company is a clinical-stage biotech with no revenue, reporting a net loss of $446.21M in 2025, but maintains strong analyst support with an 85.7% buy rating and a $35.20 consensus price target. Recent news highlights progress in Phase 1/2 trials for neuromuscular diseases and a $375M public offering in July 2026 to fund development.
The investment case hinges on clinical success, offering significant upside to the price target, but carries high risk due to pre-revenue status, dependence on trial outcomes, and negative cash flow from operations. Investor sentiment is cautiously optimistic, buoyed by analyst confidence, though volatility from sector-specific news remains a near-term challenge.
Hyatt Hotels Corporation (H) trades at $160.32, down 0.53% on the day, with a bullish technical signal and strong earnings beats in recent quarters. The stock shows a high P/E ratio of 201.14 but benefits from a strategic collaboration with Delta Air Lines and portfolio expansion. Cash flow trends indicate variability, with a net cash outflow of $227 million in 2025, while revenue grew to $7.10 billion.
The outlook is mixed: analyst consensus is a Moderate Buy with a $197.92 price target, implying 23% upside, but risks include high valuation, debt levels, and net income volatility. Growth drivers include brand expansion and loyalty partnerships, yet investors should monitor execution on profitability and macroeconomic impacts on travel demand.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Dyne Therapeutics Inc. Common Stock
Dyne Therapeutics, Inc. is a clinical-stage biotechnology company developing therapeutics for genetically driven neuromuscular diseases, including Duchenne muscular dystrophy and myotonic dystrophy type 1, with additional preclinical programs for facioscapulohumeral muscular dystrophy and Pompe disease.
Read more on DYN →About Hyatt Hotels Corporation
Hyatt is an operator of 1,162 owned (5% of total rooms) and managed and franchise (95%) properties across roughly 20 upscale luxury brands, which includes vacation brands (Apple Leisure Group, Hyatt Ziva and Hyatt Zilara), the recently launched full-service lifestyle brand Hyatt Centric, the soft lifestyle brand Unbound, and the wellness brand Miraval. Hyatt acquired Two Roads in November 2018 and Apple Leisure Group in 2021. The regional exposure as a percentage of total rooms is 66% Americas, 18% Asia-Pacific, and 16% rest of world.
Read more on H →
